Acquired by LACROIX Group.
QustomDot is developing cadmium-free quantum dots that are stable enough for advanced applications.
Flindr aims to restore a patient’s impaired immune response to cancer
EyeD Pharma is developing micro-implants for drug release over a prolonged period of time.
